Genesys Capital logo

Genesys Capital

North America, Ontario, Canada, Toronto

Description

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology.

Investor Profile

Genesys Capital has made 28 investments, with 1 in the past 12 months and 14% as lead.

Stage Focus

  • Series A (36%)
  • Series B (32%)
  • Series C (11%)
  • Series Unknown (11%)
  • Series F (4%)
  • Series E (4%)
  • Seed (4%)

Country Focus

  • United States (50%)
  • Canada (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Biopharma
  • Therapeutics
  • Oncology
  • Medical Device
  • Genetics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Genesys Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 3
Fonds de solidarité FTQ
North America, Quebec, Canada, Montréal
Co-Investments: 4
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 3
Amorchem
North America, Quebec, Canada, Montréal
Co-Investments: 4
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 5
Adams Street Partners
North America, Illinois, United States, Chicago
Co-Investments: 6
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 3
Forward Ventures
North America, California, United States, San Diego
Co-Investments: 3
Latterell Venture Partners
North America, California, United States, San Francisco
Co-Investments: 4
P
North America, Illinois, United States, Northbrook
Co-Investments: 4

Which angels does Genesys Capital often collaborate with?

LB
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Genesys Capital?

Feldan Therapeutics

Quebec, Quebec, Canada

Feldan Therapeutics has developed a patented peptide-based technology platform.

BiotechnologyTherapeutics
Series BSep 4, 2024
Amount Raised: $21,000,000
Flosonics

Sudbury, Ontario, Canada

Flosonics is a medical device company that focuses on developing non-invasive sensors to improve the management of critically ill patients.

Health CareMedicalMedical Device
Series CMar 19, 2024
Amount Raised: $20,000,000
Veralox Therapeutics

Frederick, Maryland, United States

Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series UnknownJun 20, 2023
Amount Raised: $24,000,000
Inversago Pharma

Montréal, Quebec, Canada

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series COct 17, 2022
Amount Raised: $69,264,701
Veralox Therapeutics

Frederick, Maryland, United States

Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series AJun 16, 2021
Amount Raised: $16,600,000
Giiant Pharma

Montréal, Quebec, Canada

Giiant Pharma is a preclinical-stage biotech company.

BiopharmaBiotechnologyHealth CareLife Science
SeedMay 21, 2021
Amount Raised: $12,429,875
Flosonics

Sudbury, Ontario, Canada

Flosonics is a medical device company that focuses on developing non-invasive sensors to improve the management of critically ill patients.

Health CareMedicalMedical Device
Series UnknownFeb 2, 2021
Amount Raised: $14,000,000
Inversago Pharma

Montréal, Quebec, Canada

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BSep 8, 2020
Amount Raised: $35,000,000
IDbyDNA

Salt Lake City, Utah, United States

IDbyDNA democratizes Precision Metagenomics to uncover the microbial world.

BiotechnologyHealth CareHealth DiagnosticsLife Science
Series BJan 29, 2020
Amount Raised: $20,000,000
EBT Medical

Toronto, Ontario, Canada

EBT Medical is a clinical-stage startup developing disruptive neuromodulation therapies for pelvic health disorders.

Health CareMedical Device
Series ANov 19, 2019
Amount Raised: $10,000,000